Teva API is an international pharmaceutical company headquartered in Israel. Teva API is a stand-alone business unit of Teva Pharmaceutical Industries limited, the largest generic drug manufacturer in the world [1] and one of the 15 largest pharmaceutical companies worldwide.[2]
On top of supplying a major share of Teva's own needs, the Teva API division is an active competitor in world markets, investing both in the development of new products, manufacturing processes and in the upgrading of production facilities. In 2014, Teva API's sales to third parties totaled $724 million. In recent years growth occurred in all of Teva API's principal geographical markets: North America, Europe and International.[3]
History
At the heart of the API division is the Israel-based Teva-Tech, formerly known as the Asia and Plantex plants which manufacture, develop and market raw materials for pharmaceuticals.